SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 327.20 |
| Enterprise Value ($M) | 276.86 |
| Book Value ($M) | 412.14 |
| Book Value / Share | 3.86 |
| Price / Book | 0.79 |
| NCAV ($M) | 265.56 |
| NCAV / Share | 2.49 |
| Price / NCAV | 1.23 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.59 |
| Return on Assets (ROA) | -0.52 |
| Return on Equity (ROE) | -0.52 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 9.19 |
| Current Ratio | 9.19 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 324.49 |
| Assets | 471.07 |
| Liabilities | 58.93 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -273.20 |
| Net Income | -258.75 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -209.72 |
| Cash from Investing | 131.71 |
| Cash from Financing | 185.74 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Wellington Management Group Llp | 0.90 | -85.95 | |
| 13G | Maverick Capital Ltd | 5.20 | ||
| 13D/A | Rtw Investments, Lp | 17.60 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 468,844 | 5,165,310 | 9.08 | |
| 1,033,411 | 4,395,023 | 23.51 | |
| 1,177,160 | 4,146,684 | 28.39 | |
| 1,537,107 | 7,157,712 | 21.47 | |
| 983,218 | 7,883,086 | 12.47 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| PTGX – Protagonist Therapeutics, Inc. | RANI – Rani Therapeutics Holdings, Inc. |
| RAPT – RAPT Therapeutics, Inc. | RLAY – Relay Therapeutics, Inc. |
| RNA – Avidity Biosciences, Inc. |